Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry : rationale for comprehensive management of atrial fibrillation

Tools
- Tools
+ Tools

Bassand, Jean-Pierre, Accetta, Gabriele, Al Mahmeed, Mahmeed, Corbalan, Ramon, Eikelboom, John, Fitzmaurice, David A., Fox, Keith A. A., Gao, Haiyan, Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Pieper, Karen, Turpie, Alexander G. G., Eickels, Martin van, Verheugt, Freek W. A. and Kakkar, Ajay K. (2018) Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry : rationale for comprehensive management of atrial fibrillation. PLoS One, 13 (1). e0191592. doi:10.1371/journal.pone.0191592 ISSN 1932-6203.

[img]
Preview
PDF
WRAP-risk-factors-death-stroke-bleeding-patients-rationale-atrial-fibrillation-Fitzmaurice-2018.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (2392Kb) | Preview
[img] PDF
WRAP-risk-factors-death-stroke-bleeding-28,628-patients-GARFIELD-AF-registry-Fitzmaurice-2017.pdf - Accepted Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (2204Kb)
Official URL: https://doi.org/10.1371/journal.pone.0191592

Request Changes to record.

Abstract

Background

The factors influencing three major outcomes–death, stroke/systemic embolism (SE), and major bleeding–have not been investigated in a large international cohort of unselected patients with newly diagnosed atrial fibrillation (AF).

Methods and results

In 28,628 patients prospectively enrolled in the GARFIELD-AF registry with 2-year follow-up, we aimed at analysing: (1) the variables influencing outcomes; (2) the extent of implementation of guideline-recommended therapies in comorbidities that strongly affect outcomes. Median (IQR) age was 71.0 (63.0 to 78.0) years, 44.4% of patients were female, median (IQR) CHA2DS2-VASc score was 3.0 (2.0 to 4.0); 63.3% of patients were on anticoagulants (ACs) with or without antiplatelet (AP) therapy, 24.5% AP monotherapy, and 12.2% no antithrombotic therapy. At 2 years, rates (95% CI) of death, stroke/SE, and major bleeding were 3.84 (3.68; 4.02), 1.27 (1.18; 1.38), and 0.71 (0.64; 0.79) per 100 person-years. Age, history of stroke/SE, vascular disease (VascD), and chronic kidney disease (CKD) were associated with the risks of all three outcomes. Congestive heart failure (CHF) was associated with the risks of death and stroke/SE. Smoking, non-paroxysmal forms of AF, and history of bleeding were associated with the risk of death, female sex and heavy drinking with the risk of stroke/SE. Asian race was associated with lower risks of death and major bleeding versus other races. AC treatment was associated with 30% and 28% lower risks of death and stroke/SE, respectively, compared with no AC treatment. Rates of prescription of guideline-recommended drugs were suboptimal in patients with CHF, VascD, or CKD.

Conclusions

Our data show that several variables are associated with the risk of one or more outcomes, in terms of death, stroke/SE, and major bleeding. Comprehensive management of AF should encompass, besides anticoagulation, improved implementation of guideline-recommended therapies for comorbidities strongly associated with outcomes, namely CHF, VascD, and CKD.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Atrial fibrillation -- Diagnosis -- Standards, Embolism
Journal or Publication Title: PLoS One
Publisher: Public Library of Science
ISSN: 1932-6203
Official Date: 25 January 2018
Dates:
DateEvent
25 January 2018Available
8 January 2018Accepted
Volume: 13
Number: 1
Article Number: e0191592
DOI: 10.1371/journal.pone.0191592
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 24 January 2018
Date of first compliant Open Access: 8 May 2018
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDBayer AGhttp://viaf.org/viaf/134841299
Related URLs:
  • Publisher
Contributors:
ContributionNameContributor ID
Research GroupGARFIELD-AF Investigators, UNSPECIFIED

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us